Bayes Entrepreneurship Fund

The fund functions as the dedicated early-stage investment vehicle affiliated with Bayes Business School, which is part of City, University of London. It channels capital into ventures founded by students, alumni and researchers connected to the school, operating as a captive pipeline for commercialization rather than an independent third-party manager. The arrangement integrates academic entrepreneurship programs directly with seed-stage funding.

The fund concentrates on seed and early-stage investments, typically acting as a first-check or early institutional investor alongside angel syndicates. Its mandate prioritizes ventures that have emerged from the university's incubators, accelerator programs and research labs, bridging the gap between grant funding and Series A. Later-stage follow-on investments are possible but secondary to the initial deployment.

Deal flow originates primarily through internal university channels — the school's entrepreneurship institute, alumni networks, faculty research commercialization offices and on-campus pitch competitions. This closed-loop sourcing distinguishes the fund from market-facing VCs, as it relies on academic affiliation rather than broker networks or outbound origination teams.

Public indications point to a focus on enterprise software, fintech and digital health, consistent with the research strengths and graduate startup activity at Bayes Business School. The fund may also explore adjacent areas like data analytics and business services where the school has faculty expertise, but it does not appear to pursue deep tech, hardware or life sciences requiring specialized scientific infrastructure.

No. The fund maintains a low public profile typical of university-linked vehicles that are not actively marketing to external limited partners. Specific portfolio holdings, total deployment and AUM have not been published, making third-party benchmarking difficult. This opacity is consistent with vehicles that operate as extensions of institutional endowment or internal balance-sheet commitments rather than as broad LP-funded blind pools.